Showing 67,921 - 67,940 results of 68,312 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 5 ((g decrease) OR (a decrease)) ))', query time: 1.15s Refine Results
  1. 67921
  2. 67922
  3. 67923
  4. 67924
  5. 67925
  6. 67926

    Image_1_Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.tif by Chenguang Niu (1485637)

    Published 2023
    “…<p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is a phenotype of liver diseases associated with metabolic syndrome. …”
  7. 67927

    DataSheet_1_New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients.docx by Cecilie Fredvik Torkildsen (6030020)

    Published 2024
    “…Serum cytokine profiling is a sensitive measure of immune adaption and deviation, yet its integration into treatment paradigms is underexplored. …”
  8. 67928

    Table1_Genome-wide SNP analysis of Plasmodium falciparum shows differentiation at drug-resistance-associated loci among malaria transmission settings in southern Mali.XLSX by Aoua Coulibaly (13901043)

    Published 2022
    “…The complexity of infections remained high, varied between sites, and showed a trend toward overall decreasing complexity over the decade. …”
  9. 67929

    DataSheet1_Genome-wide SNP analysis of Plasmodium falciparum shows differentiation at drug-resistance-associated loci among malaria transmission settings in southern Mali.PDF by Aoua Coulibaly (13901043)

    Published 2022
    “…The complexity of infections remained high, varied between sites, and showed a trend toward overall decreasing complexity over the decade. …”
  10. 67930

    Image_2_Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.tif by Chenguang Niu (1485637)

    Published 2023
    “…<p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is a phenotype of liver diseases associated with metabolic syndrome. …”
  11. 67931
  12. 67932
  13. 67933

    Table_1_Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort.XLSX by Jade E. Kenna (7147769)

    Published 2021
    “…Differences were found in two phyla (Synergistetes and Proteobacteria; both increased in PwP), and five genera (Colidextribacter, Intestinibacter, Kineothrix, Agathobaculum, and Roseburia; all decreased in PwP). …”
  14. 67934

    Table_2_Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort.docx by Jade E. Kenna (7147769)

    Published 2021
    “…Differences were found in two phyla (Synergistetes and Proteobacteria; both increased in PwP), and five genera (Colidextribacter, Intestinibacter, Kineothrix, Agathobaculum, and Roseburia; all decreased in PwP). …”
  15. 67935

    Data_Sheet_1_Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort.DOCX by Jade E. Kenna (7147769)

    Published 2021
    “…Differences were found in two phyla (Synergistetes and Proteobacteria; both increased in PwP), and five genera (Colidextribacter, Intestinibacter, Kineothrix, Agathobaculum, and Roseburia; all decreased in PwP). …”
  16. 67936
  17. 67937
  18. 67938
  19. 67939
  20. 67940